Shilpa Medicare Ltd.

₹388.9

14.2 (3.8%)

SHILPAMED Share Price

Pharmaceuticals & Biotechnology

As on April 2, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 7,583 Cr

P/E Ratio97.15

Dividend Yield0.26 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	361.48	Bullish
10-DMA	342.03	Bullish
20-DMA	333.99	Bullish
50-DMA	319.27	Bullish
100-DMA	326.99	Bullish
200-DMA	371.71	Bullish

Historical Performance

1 Year

20%

3 Years

239.9%

5 Years

121.5%

10 Years

80.6%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	12,864	11,516	10,501	11,455	9,011
Total Expenditure	9,825	9,161	9,618	9,483	7,294
Other Income	363	172	314	209	401
Operating Profit	3,402	2,527	1,197	2,181	2,118
Interest	755	918	587	412	219
Depreciation	1,130	1,079	955	798	540
Profit Before Tax	1,223	543	-383	1,023	1,951
Consolidated Net Profit	783	319	-325	607	1,478
Adjusted EPS	4	2	-2	3	9

Compounded Sales Growth

10 Years:16

5 Years:7.2

3 Years:2.3

TTM:2.2

Compounded Profit Growth

10 Years:1.2

5 Years:-12.9

3 Years:5.2

TTM:19.7

Stock Price CAGR

10 Years:6.1

5 Years:17.2

3 Years:49.6

TTM:14.9

Return on Equity

10 Years:7

5 Years:9.1

3 Years:-1.9

last year:4

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	98	87	87	87	82
Total Reserves	23,625	18,000	17,746	18,135	14,705
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	2,598	5,894	3,451	4,528	5,614
Other Current Liabilities	2,221	1,380	2,766	2,401	2,542
Short Term Borrowings	3,068	3,607	3,442	2,029	2,434
Total Liabilities	32,977	30,830	29,039	28,755	26,324
Capital Work in Progress	4,625	4,030	3,580	1,900	3,021
Long Term Loans & Advances	365	533	565	939	431
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	1,508	912	883	1,022	1,462
Total Current Assets	9,857	8,762	7,696	8,872	8,625
Total Assets	32,977	30,830	29,039	28,755	26,324
Adjusted Book Value	121	104	205	210	181

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 97.15, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 49.6%, indicating sustained price appreciation.
The stock carries a beta of 1.2, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹3402 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹12864 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1149316.6

No. of Shares: 2955 (Approx)

Performance:14.9%

P/L: ₹149316.6

NIFTY Performance: -2.3%

1 day Top Gainers